Crossject

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. Show More...

  • Website https://www.crossject.com
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Last Quote 1.82 EUR
  • Last Updated 30-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2009-12 2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 TTM
    Earnings Per Share EUR -0.93 0.35 -0.21 -0.41 -0.62 -0.82 -0.85 -0.85 -0.79 -0.71
    Dividends EUR
    Payout Ratio % *
    Shares Mil 4.0 4.0 4.0 5.0 8.0 8.0 9.0 10.0 19.0 18.0
    Book Value Per Share * EUR 2.39 1.66 1.0 0.69 0.18 0.11
    Free Cash Flow Per Share * EUR -1.0 -0.63 -0.8 -0.58 -1.0
    Return on Assets % -154.03 55.55 -33.77 -44.22 -36.1 -35.26 -47.38 -47.62 -56.56 -72.0
    Financial Leverage (Average) 3.54 1.21 1.35 2.27 2.91 12.18 7.96
    Return on Equity % -51.83 -44.76 -80.48 -123.06 -276.78 -560.09
    Return on Invested Capital % -51.54 -44.66 -73.47 -105.77 -118.48 -144.2
    Interest Coverage -11.23 -144.64 -355.47 -220.46 -480.78 -51.85 -39.1
    Current Ratio 0.27 0.86 0.78 1.73 4.42 2.44 0.75 1.07 0.57
    Quick Ratio 0.07 0.23 0.18 1.31 3.92 1.58 0.34 0.62 0.18
    Debt/Equity 0.93 0.16 5.49 2.26